India’s Public Hospitals Struggle as Private Equity Circles Profitable Healthcare Sector
From colonial-era charity wards to a two-tier system where corporate chains eye billion-dollar deals, India’s health infrastructure reveals deep divides—and growing investor appetite.
India’s public hospitals, long the backbone of its healthcare system, are facing a paradox: while millions rely on them for free or subsidized care, private equity firms are pouring billions into the country’s lucrative private hospital chains. Recent reports of high-stakes deals involving Maxivision Eye Care and Medicover’s Indian arm underscore a widening gap between public and private healthcare—one that raises questions about equity, access, and the future of India’s health system.
What Happened
In the past month, two major private hospital operators in India have made headlines for attracting significant private equity interest. Maxivision Eye Care, backed by Singapore-based Quadria Capital, has reportedly hired investment bankers to explore an initial public offering (IPO), according to sources cited by Reuters. Meanwhile, global investment firm KKR is in advanced talks to acquire a stake worth at least $1 billion in Medicover’s Indian hospital business, another Reuters source revealed.
These developments follow a broader trend of private equity and corporate investment in India’s healthcare sector, which has grown rapidly over the past decade. The country’s private hospital market, valued at over $100 billion, is projected to expand at a compound annual growth rate (CAGR) of 16% through 2027, driven by rising incomes, urbanization, and a growing middle class willing to pay for quality care.
Why It Matters
The surge in private investment contrasts sharply with the state of India’s public hospitals, which serve as the primary healthcare provider for the majority of the population. While private hospitals offer cutting-edge technology and shorter wait times, they cater largely to the affluent or those with insurance. Public hospitals, on the other hand, are often overcrowded, underfunded, and understaffed—yet they remain the only option for India’s poor and rural populations.
This two-tier system has significant implications for health equity. India’s public health spending remains among the lowest in the world, at just 1.2% of GDP, far below the global average of 6%. The World Health Organization (WHO) recommends that countries allocate at least 5% of GDP to health to ensure universal coverage. The gap leaves public hospitals struggling with shortages of beds, doctors, and essential medicines, while private hospitals expand their footprint with investor backing.
Evidence and Source Trail
The Reuters reports on Maxivision and Medicover provide the latest evidence of private equity’s growing role in India’s healthcare sector. Maxivision, which operates a chain of eye care hospitals, has been expanding aggressively across southern India, while Medicover’s Indian arm runs multi-specialty hospitals in several states. Neither company has disclosed financial details, but industry analysts suggest that both are positioning themselves for rapid growth ahead of potential IPOs or stake sales.
The broader trend of private investment in healthcare is well-documented. A 2023 report by Bain & Company and the Indian Private Equity & Venture Capital Association (IVCA) found that healthcare was the second-most active sector for private equity investments in India in 2022, with deals worth $3.2 billion. Hospitals and diagnostics accounted for the largest share of these investments, reflecting investor confidence in the sector’s growth potential.
In contrast, public hospitals continue to grapple with systemic challenges. A 2022 study published in The Lancet found that India’s public health system suffers from severe shortages of healthcare workers, with just one government doctor for every 10,189 people—far below the WHO’s recommended ratio of 1:1,000. The study also highlighted disparities in access to care, with rural areas facing acute shortages of specialists and infrastructure.
Background/Context
India’s healthcare system has evolved significantly since independence in 1947. The colonial-era system was built around charity hospitals and missionary-run facilities, which provided free or low-cost care to the poor. After independence, the government expanded public healthcare through a network of primary health centers (PHCs), community health centers (CHCs), and district hospitals. The goal was to provide universal access to basic healthcare, with a focus on preventive and primary care.
However, the system has struggled to keep pace with India’s growing population and rising disease burden. Public hospitals, which account for about 40% of all hospital beds in the country, are often overwhelmed by patient loads. A 2021 report by the National Health Systems Resource Centre (NHSRC) found that public hospitals in India operate at an average bed occupancy rate of 116%, far exceeding the ideal rate of 80-85%. This overcrowding leads to long wait times, poor patient outcomes, and high rates of hospital-acquired infections.
Meanwhile, the private sector has grown rapidly since the 1990s, fueled by economic liberalization and rising demand for quality healthcare. Private hospitals now account for 60% of all hospital beds in India, and their share is growing. Many of these hospitals are part of large corporate chains, such as Apollo Hospitals, Fortis Healthcare, and Max Healthcare, which offer advanced medical treatments and attract patients from across the country—and even abroad.
Competing Claims or Uncertainty
The rise of private equity in healthcare has sparked debate about its impact on access and affordability. Proponents argue that private investment drives innovation, improves efficiency, and expands access to care by increasing the supply of hospital beds and medical services. They point to the success of chains like Apollo Hospitals, which has brought world-class healthcare to millions of Indians.
Critics, however, warn that private equity’s focus on profitability could exacerbate inequalities in the healthcare system. A 2022 investigation by The Wire found that private hospitals in India often overcharge patients for treatments, leading to financial ruin for many families. The investigation cited cases where patients were billed exorbitant sums for basic procedures, such as caesarean sections or cardiac surgeries, with little transparency or regulation.
There is also uncertainty about the long-term impact of private equity on public hospitals. Some experts fear that the growth of private healthcare could divert resources and talent away from the public sector, further weakening an already strained system. Others argue that private investment could complement public healthcare by filling gaps in services and infrastructure.
What to Watch Next
The next few months could see significant developments in India’s healthcare sector. Maxivision’s potential IPO and KKR’s stake acquisition in Medicover’s Indian arm are likely to set the tone for future investments. Investors will be watching closely to see how these deals perform, as they could signal the sector’s attractiveness for further capital inflows.
On the policy front, the Indian government has taken steps to address gaps in public healthcare, including the launch of the Ayushman Bharat scheme in 2018. The program aims to provide health insurance coverage to 500 million low-income Indians, with a focus on secondary and tertiary care. However, critics argue that the scheme has been underfunded and poorly implemented, with many beneficiaries struggling to access care due to a lack of empanelled hospitals in rural areas.
Another key development to watch is the government’s plan to increase public health spending. In 2021, the Union Budget announced a 137% increase in health expenditure, with a focus on strengthening primary healthcare and expanding the network of PHCs and CHCs. However, progress has been slow, and it remains to be seen whether the government can meet its targets.
Conclusion
India’s healthcare system stands at a crossroads. The rapid growth of private hospitals, fueled by private equity investment, offers the promise of expanded access and improved quality of care for those who can afford it. Yet, for the millions who rely on public hospitals, the system remains overstretched and underfunded. The challenge for policymakers is to ensure that the benefits of private investment are not confined to the wealthy but are leveraged to strengthen the public health system and improve outcomes for all Indians.
As private equity firms circle India’s healthcare sector, the question remains: will the country’s health system become more equitable, or will the divide between public and private care grow even wider?
Source: Reuters reports on Maxivision and Medicover (Google News), Bain & Company/IVCA 2023 report, The Lancet 2022 study, NHSRC 2021 report, The Wire 2022 investigation.
Corrections
If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.
Story synopsis gathered from: multiple sources — source.
